Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e446015802f9010bbde5985ee3b45d25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec9adf601a1cdf221a9867193e5b7b96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fffda8b59ac378c0e7cd94cdf51bbfd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48f9325de8088c0a2b24288fb5646da8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6816 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6816 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
filingDate |
2019-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f77581611357e290a654103ddfb56179 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c5bfdf1034794d9388922642cb76308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26c51b7a2a0d830c920996599a48c04b |
publicationDate |
2019-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2019199684-A1 |
titleOfInvention |
Methods and systems for biocellular marker detection and diagnosis using a microfluidic profiling device |
abstract |
The present disclosure relates to the use of microfluidic devices and systems to generate dynamic molecular signatures based on the detection of various biocellular markers. In particular, the present disclosure involves generating a dynamic molecular signature or profile using the cells of a subject (e.g., circulating monocytes), for various diagnostic and prognostic purposes, such as characterizing a disease or non-disease state, or predicting drug responsiveness. The microfluidic systems and methods of the present disclosure can be used to rapidly assess a plurality of clinical characteristics, which will ultimately enhance therapeutic efficacy and facilitate disease risk stratification. |
priorityDate |
2018-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |